Eliaz Therapeutics Inc. — Form D

Eliaz Therapeutics Inc. of SANTA ROSA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-24. The offering totals $850K, of which $850K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-10-24
• Form: D
• Accession: 0001062993-25-016285
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $850K
• Amount sold: $850K
• Minimum investment: $100K
• Investors: 4
• Date of first sale: 2025-03-28
• Revenue range: Decline to Disclose
• SEC file number: 021-562048

Issuer

• Name: Eliaz Therapeutics Inc.
• CIK: 0002042609
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 398 TESCONI COURT, SANTA ROSA, CA, 95401
• Phone: 707 542-5856

Officers, directors & promoters (3)

More

• CIK 2042609 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search